Southern Company (NYSE: SO ) reported earnings Wednesday, matching revenue expectations but slightly underwhelming on earnings. With costs headed higher, let's take a look to see if this dividend stock is priced for perfection.
Number crunching
On top-line growth, Southern nailed it. The utility pulled in $3.9 billion in sales, 8.1% higher than Q1 2012 and a respectable 4% above analyst expectations.
On adjusted earnings, Southern managed just fine. Diluted EPS clocked in at $0.49, missing the market's $0.50 prediction by one cent.
But to make money, you have to spend money, and Southern spent more than Wall Street (or the company itself) expected. Unadjusted earnings added up to $0.09 EPS, compared with $0.42 for last year's first quarter.
The two main cost culprits: (1) a $16 million after-tax charge from restructuring a leveraged lease investment and (2) a $333 million after-tax charge for increased construction costs at a new Kemper County, Miss., power plant.
Top 10 India Stocks To Invest In 2015: Ishares Trust Dow Jones United States Financial (IYG)
iShares Dow Jones U.S. Financial Services Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Financial Services Index (the Index). The Index measures the performance of the financial services sector of the United States equity market and is a subset of the Dow Jones U.S. Financials Index. The Index includes companies in sectors, such as banks and investment management/brokers.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Mary Anne & Pamela Aden]
So, for now, the US stock market is the best overall market. So continue holding the stocks you have, which are mostly doing very well. If you want to buy new positions and increase your stock allocation, the following ETFs are among the strongest ETFs, and we recommend them for purchase: SPDR KBW Bank (KBE)
Consumer Discretionary SPDR (XLY)
Merrill Lynch Retail HOLDRS (RTH)
iShares Dow Jones US Financial Service (IYG)
PowerShares Dynamic Leisure & Entertainment (PEJ)
Subscribe to The Aden Forecast here��/P>
Top 10 Heal Care Stocks To Buy Right Now: Tableau Software Inc (DATA)
Tableau Software, Inc., incorporated on July 19, 2004, is a computer software company. The Company�� products are used by people across all kinds of organizations, including Fortune 500 corporations, small and medium-sized businesses, government agencies, universities, research institutions and non-profits. Organizations employ its products in a range of use cases, such as increasing sales, streamlining operations, improving customer service, managing investments, assessing quality and safety, studying and treating diseases, completing academic research, addressing environmental problems and improving education. The Company�� product helps a single user on a laptop analyze data from a simple spreadsheet, or to enable thousands of users across an enterprise to execute queries against databases.
The Company�� technology includes VizQL and its Hybrid Data Architecture. VizQL, translates drag-and-drop actions into data queries and then expresses that information visually. VizQL unifies the formerly disparate tasks of query and visualization and allows users to transform questions into pictures without the need for software scripts, chart wizards or dialogue boxes that inhibit speed and flexibility. The Company�� Hybrid Data Architecture combines the power and flexibility of its Live Query and In-Memory Data Engines. The Company�� Live Query Engine allows users to instantaneously connect to volumes of data in its existing format and location, reducing the need for time-consuming data transformation processes that only technical specialists can perform. In addition, this capability allows customers to leverage investments in their existing data platforms and to capitalize on the capabilities of high performance databases. The Company�� In-Memory Data Engine enables users to import amounts of data into its own in-memory database.
Advisors' Opinion:- [By Telis Demos and Douglas MacMillan Opower Inc., which helps electric utilities push homeowners to use]
A steady stream of so-called “big data” companies like Opower have gone public lately, including software firms Splunk Inc.(SPLK) and Tableau Software Inc.(DATA) Those stocks have each more than doubled since their debuts in 2012 and earlier this year, respectively.
- [By Lauren Pollock]
Tableau Software Inc.'s(DATA) third-quarter profit increased more than sixfold driven by another surge in revenue. Revenue jumped 90% to $61.1 million in the quarter as the company reported growth in customer accounts. Shares of Tableau rose 10% to $69.50 premarket as the results beat expectations.
- [By John Kell]
Tableau Software Inc.(DATA) swung to a surprise fourth-quarter profit as the business software maker’s revenue surged again. The company’s adjusted earnings and revenue beat expectations, pushing shares up 12% to $88.70 premarket.
Top 10 Heal Care Stocks To Buy Right Now: BP Prudhoe Bay Royalty Trust (BPT)
BP Prudhoe Bay Royalty Trust operates as a grantor trust in the United States. The company holds overriding royalty interests constituting a non-operational interest in minerals in the Prudhoe Bay oil field located on the North Slope in Alaska. The Prudhoe Bay field extends approximately 12 miles by 27 miles and contains approximately 150,000 gross productive acres. As of December 31, 2012, its estimated net remaining proved reserves were 75.517 million barrels of oil and condensate, of which 70.676 million barrels are proved developed reserves and 4.841 million barrels are proved undeveloped reserves. The company was founded in 1989 and is based in Austin, Texas.
Advisors' Opinion:- [By Rick Munarriz]
BP Prudhoe Bay Royalty Trust (NYSE: BPT ) is also fueling its distributions. The trust's new quarterly payout comes out to $2.4147517 a unit. We're really splitting pennies here, but it's actually a reasonable 4% increase over its earlier rate.
- [By Aaron Levitt]
BP Prudhoe Bay Royalty Trust (BPT): BPT is the largest conventional oil and gas trust in the U.S. and was originally formed in 1989 by BP (BP). The royalty trust collects fees on the first 90,000 barrels of oil collected in the massive Prudhoe Bay oil field located on Alaska’s North Slope. While production in Prudhoe Bay have slipped over the last few years, BPT is expected to continue pumping out dividends for another 15 years. This royalty trust�yields a very hefty 11% based on the last four distributions.
- [By Matt DiLallo]
BP Prudhoe Bay Royalty Trust (NYSE: BPT )
Created in 1989, the property of the BP Prudhoe Bay Royalty Trust consists of an overriding royalty interest of oil and condensate production from BP's Prudhoe Bay oil field located on the North Slope in Alaska. The trust makes quarterly payments to investors of the income after expenses, which can vary each quarter. Over the past year the trust has paid out an average of $2.22 per quarter which would imply a yield of around 9.4%. The key point that investors must understand is that the oil in the field is a finite resource, meaning that it will run out. Under current projections it's expected that the trust will run dry around the year 2029.
Top 10 Heal Care Stocks To Buy Right Now: Mylan Inc (MYL)
Mylan Inc. (Mylan), incorporated in 1970, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. Through Mylan Laboratories Limited, an Indian subsidiary, it manufactures and supply active pharmaceutical ingredient (API) for its own products and pipeline, as well as for third parties. On December 23, 2011, Mylan completed the acquisition of rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline�� Advair Diskus and Seretide Diskus incorporating Pfizer Inc.��, (Pfizer) dry powder inhaler delivery platform (the Respiratory Delivery Platform). In February 2012, Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to the Company.
As of December 31, 2011, Mylan marketed a global portfolio of approximately 1,100 different products covering a range of therapeutic categories. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids. In addition, it focuses on transdermal patches, high potency formulations, injectables, controlled release and respiratory delivery products. Mylan operates in two segments: Generics and Specialty. Its revenues are derived from the sale of generic and branded generic pharmaceuticals, specialty pharmaceuticals and API. Its generic pharmaceutical business is conducted in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA), and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited, which is included within the Asia Pacific region in its Generi! cs segment. Its specialty pharmaceutical business is conducted by Dey Pharma, L.P. (Dey).
Generics Segment
The Company sales in the United States are derived through its wholly owned subsidiary Mylan Pharmaceuticals Inc. (MPI), its primary United States pharmaceutical research, development, manufacturing, marketing and distribution subsidiary, as well as through Mylan Institutional (MI). MPI�� net revenues are derived from the sale of solid oral dosage and transdermal patch products. MI�� net revenues are derived from the sale of its unit dose and injectable product offerings. In the United States, it has product portfolios consisting of approximately 340 products, of which approximately 305 are in capsule or tablet form in an aggregate of approximately 740 dosage strengths. Included in these totals are approximately 40 extended release products in a total of approximately 105 dosage strengths. Also included in it�� the United States product portfolio are four transdermal patch products in a total of 18 dosage strengths, which are developed and manufactured by Mylan Technologies, Inc. (MTI), its wholly owned transdermal technology subsidiary, and marketed and distributed by MPI.
The Company�� North America revenues also include those generated by its wholly owned subsidiary Mylan Pharmaceuticals ULC (MPC), which markets generic pharmaceuticals in Canada. MPC offers a portfolio of approximately 115 products in an aggregate of approximately 250 dosage strengths. Its generic pharmaceutical sales in EMEA are generated by its wholly owned subsidiaries in Europe, through which it has operations in 21 countries.
In France, through the Company�� subsidiary Mylan S.A.S., it markets a retail portfolio of approximately 215 products in an aggregate of approximately 455 dosage strengths. In Italy, it markets through its subsidiary Mylan S.p.A. a portfolio of approximately 150 products in an aggregate of approximately 285 dosage strengths. In Italy, it h! as market! share, based on value and volume, in the company-branded generic retail prescription market. In Spain, it markets through its subsidiary Mylan Pharmaceuticals S.L. a portfolio of approximately 100 products in an aggregate of approximately 220 dosage strengths. In Germany, it markets through its subsidiary Mylan dura a portfolio of approximately 150 products in an aggregate of approximately 330 dosage strengths. In the United Kingdom, it offers a product portfolio of approximately 175 products in an aggregate of approximately 315 dosage strengths. It markets generic pharmaceuticals in Asia Pacific through subsidiaries in Australia, New Zealand, India, Japan and Taiwan.
In Australia, the Company offers a portfolio of approximately 170 products in an aggregate of approximately 440 dosage strengths. Mylan Seiyaku, its wholly owned Japanese subsidiary, offers a portfolio of more than 380 products in an aggregate of approximately 500 dosage strengths. At Mylan Laboratories Limited, its dosage business produces antiretroviral (ARV) products, which are sold outside of India, and other finished dosage form (FDF) products, which are sold to third parties by other Mylan operations globally. In addition, Mylan Laboratories Limited offers a line of FDF products in the ARV market and manufactures non-ARV FDF products that are marketed by Mylan.
Specialty Segment
The Company�� specialty pharmaceutical business is conducted through Dey. Dey�� portfolio consists of branded specialty injectable, nebulized and transdermal products for life-threatening conditions. Dey�� revenues are derived through the sale of the EpiPen Auto-Injector. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector that has been sold in the United States and internationally.
Advisors' Opinion:- [By Laura Brodbeck]
Thursday
Earnings Expected From: Barrick Gold Corporation (NYSE: ABX), Newmont Mining Corporation (NYSE: NEM), Mastercard Incorporated (NYSE: MA), Mylan, Inc (NASDAQ: MYL), Time Warner Cable Inc. (NYSE: TWC) Economic Releases Expected: Chinese manufacturing PMI, South Korean trade balance, US Personal income, Italian PPI, eurozone unemployment rate, French consumer spending, Spanish current accountFriday
- [By Ben Levisohn]
Mylan (MYL) wants to start preparing a generic version of two Celegene (CELG) drugs. Celegene obviously wants to make that as difficult as possible. And now they’re heading to court.
Reuters has the details on Mylan’s lawsuit against Celgene:
In its lawsuit filed in the U.S. District Court in Newark, New Jersey, Mylan accused Celgene of using federal limits on the distribution of Revlimid and Thalomid, which were designed to promote the drugs’ safety, as a pretext to keep generic drug makers from obtaining their own samples…
The lawsuit seeks to force Celgene to sell Mylan enough Revlimid and Thalomid at market prices to allow for bioequivalence testing. It also seeks compensation for Mylan’s inability to sell generic versions of both, and triple damages.
Barclays’ Ying Huang and team believe the odds favor Celgene over Mylan:
It is our understanding that [Celgene] has no obligation to provide samples of Revlimid to generic manufacturers. The Risk Evaluation and Mitigation Strategies (REMS) program required by the FDA for Revlimid also makes it difficult to obtain the product on the open market. Patients and physicians are required under REMS to register in a database administered by�[Celgene] before Revlimid is distributed. We note the REMS program argument has been upheld by the court in previous generic litigation cases.
Shares of Celgene have dropped 4.1% to $137.79 at 2:28 p.m., while Mylan has gained 2.3% to $51.02.
- [By Ben Levisohn]
The stock market has dropped today as global economic disappointed and investors abandon some of the market’s highest-flying stocks, including Netflix (NFLX), Alexion Pharmaceuticals (ALXN), Facebook (FB), Mylan (MYL) and Michael Kors (KORS).
- [By Sean Williams]
Veloci-Raptor time?
First up is Raptor Pharmaceuticals (NASDAQ: RPTP ) with Procysbi (previously known as RP-103), its oral delayed and extended-release medication to treat nephropathic cystinosis. In trials, Procysbi proved to be non-inferior to the only other FDA-approved treatment for nephropathic cystinosis, known as Cystagon from Mylan (NASDAQ: MYL ) .
Top 10 Heal Care Stocks To Buy Right Now: CSB Bancorp Inc (CSBB)
CSB Bancorp, Inc. (CSB), incorporated in 1991, is a financial holding company. The Commercial and Savings Bank of Millersburg, Ohio (the Bank) is a wholly owned subsidiary of the Company. CSB operates primarily through the Bank and its other subsidiaries, providing a range of banking, trust, financial and brokerage services to corporate, institutional and individual customers throughout northeast Ohio. The Bank provides retail and commercial banking services to its customers, including checking and savings accounts, time deposits, individual retirement accounts (IRAs), safe deposit facilities, personal loans, commercial loans, real estate mortgage loans, installment loans, night depository facilities, brokerage and trust services.
Lending Activities
The Bank provides residential real estate, commercial real estate, commercial and consumer loans to customers located primarily in Holmes, Tuscarawas, Wayne, Stark and portions of surrounding counties in Ohio. Commercial loan rates are variable as well as fixed, and include operating lines of credit and term loans made to small businesses, primarily based on their ability to repay the loan from the cash flow of the business. Business assets, such as equipment, accounts receivable and inventory typically secure such loans. Commercial real estate loans are primarily secured by borrower-occupied business real estate. Commercial real estate loans are generally originated with a loan-to-value ratio of 80% or less. Commercial construction loans are secured by commercial real estate and in most cases the Bank also provides the permanent financing. Residential real estate loans carry both fixed and variable rates and are secured by the borrower�� residence. Home equity lines of credit are made to individuals and are secured by second or first mortgages on the borrower�� residence. Installment loans to individuals include loans secured by automobiles and other consumer assets, including second mortgages on personal residences.
Investment Activities
As of December 31, 2011, the Company�� securities available-for-sale totaled $123,026,000. Its portfolio of securities available-for-sale includes the United States treasury securities, the United States Government corporations and agencies, mortgage-backed securities, obligations of states and political subdivisions, equity securities, and corporate bonds.
Sources of Funds
As of December 31, 2011, the Company�� portfolio of deposits included noninterest-bearing demand, interest-bearing demand deposits, savings deposits and time deposits. Short-term borrowings consist of securities sold under agreements to repurchase, short-term advances through Federal Home Loan Bank and federal funds purchased.
Advisors' Opinion:- [By CRWE]
Today, CSBB remains (0.00%) +0.000 at $18.75 thus far (ref. google finance Delayed: 3:53PM EDT July 30, 2013).
CSB Bancorp, Inc. previously reported second quarter 2013 net income of $1.25 million or $.45 per basic and diluted share, as compared to $1.14 million or $.41 per basic and diluted share for the same period in 2012.
Annualized returns on average common equity (��OE�� and average assets (��OA�� for the quarter were 9.32% and 0.88%, respectively, compared with 8.98% and 0.82% for the second quarter of 2012.
Eddie Steiner, President and CEO commented, ��e continue to focus on growing relationships with current and new customers. The bank�� average loan balances have increased 10% in the past year, and although margins remain tight, this growth has provided increases of approximately 4% in net interest income.��/p>
Top 10 Heal Care Stocks To Buy Right Now: Piper Jaffray Companies(PJC)
Piper Jaffray Companies provides investment banking, institutional brokerage, asset management, and related financial services to corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States, Asia, and Europe. The company raises capital through equity financings; provides advisory services, primarily relating to mergers and acquisitions for its corporate clients; underwrites debt issuances; and offers financial advisory and interest rate risk management services. Its public finance investment banking capabilities focus on state and local governments, as well as healthcare, higher education, housing, hospitality, transportation, and commercial real estate industries, as well as operates in business and financial services, clean technology and renewables, consumer, and industrial growth, as well as media, telecommunications, and technology industries. The company also offers equity and fixed income advisory and t rade execution services for institutional investors, and government and non-profit entities; and is involved in proprietary trading, as well as has equity sales and trading relationships with institutional investors. In addition, it provides asset management services to separately managed accounts, private funds or partnerships, and open-end and closed-end registered investment companies or funds; and offers an array of investment products comprising small and mid-cap value equity, and master limited partnerships focused on the energy industry, as well as fixed income. Further, the company engages in merchant banking activities, which comprises proprietary debt or equity investments in late stage private companies, and investments in private equity and venture capital funds, as well as other firm investments and forfeiture of stock-based compensation. Piper Jaffray Companies was founded in 1895 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By victorselva]
The Charles Schwab Corporation (SCHW) is a savings and loan holding company. The company is engaged, through its subsidiaries, in securities brokerage, banking, money management, and financial advisory services. Its subsidiaries include Charles Schwab & Co. (a leading discount broker-dealer), Charles Schwab Investment Management (a mutual fund investment advisor) and Charles Schwab Bank.In this article, let's take a look at this brokerage firm and try to explain to investors the reasons this is an apparently appealing investment opportunity.The FocusThe company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services. The Investor Services segment provides retail brokerage and banking services to individual investors. The Institutional Services segment provides custodial, trading, and support services to independent investment advisors. The Institutional Services segment also provides retirement plan services, specialty brokerage services, and mutual fund clearing services. The company seeks to meet the financial services needs of investors, advisers and employers. It focuses on building client loyalty with the goal of attracting new clients and serving them. Additionally, Schwab麓s strengths through shared core processes and technology advances which help create services that are scalable and consistent with the business.Interest Rates, Capital Structure and Debt-to-Capital RatioThe results are dependent on short-term interest rates, as 37% of its top line came from net interest income in the first quarter of 2014.The broker has been making significant efforts to become less dependent on interest rates, which we expect Federal Reserve will raise them in late 2014 or 2015. Also, the company麓s plan is to reach a low-cost capital structure and targets a long-term debt-to-total financial capital ratio of less than 30%.Lucrative Derivatives Trading In 2011, the company acquired Compl
- [By EXPstocktrader]
3) Piper Jaffray (PJC): Recent weakness is unwarranted as the landscape for Acthar remains favorable: OVERWEIGHT (BUY) rating and $74 PT
4) CRT Capital: BUY rating and $79 PT.
- [By Rich Smith]
Investment banker Piper Jaffray (NYSE: PJC ) expanded its municipal debt business Wednesday, when it purchased Seattle-Northwest Securities in a transaction valued at approximately $21 million.
Top 10 Heal Care Stocks To Buy Right Now: Coca Cola Femsa S.A.B. de C.V. (KOF)
Coca Cola FEMSA, S.A.B. de C.V. produces, markets, and distributes Coca-Cola trademark beverages and brands. It offers colas under Coca-Cola, Coca-Cola Light, and Coca-Cola Zero brands; flavored sparkling beverages under Aquarius Fresh, Chinotto, Crush, Fanta, Fresca, Frescolita, Hit, Kuat, Lift, Mundet, Quatro, Simba, and Sprite brands; water under Alpina, Brisa, Ciel, Crystal, Kin, Manantial, and Nevada brands; Aquarius, a flavored water; Hi-C, a juice-based beverage; and Powerade, an isotonic, as well as ready to drink tea products under Nestea and Matte Leao brands. The company also sells and distributes the Kaiser beer brand. It operates in Mexico, Central America, Colombia, Venezuela, Brazil, and Argentina. The company was founded in 1979 and is based in Mexico, Mexico. Coca-Cola FEMSA S.A.B de C.V. operates as a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Advisors' Opinion:- [By Eric Volkman]
Put another tick in the acquisition column for Coca-Cola FEMSA (NYSE: KOF ) . The Mexico-based company, which says it is the largest bottler of Coca-Cola products on the planet, has signed a deal to acquire Brazilian peer Companhia Fluminense de Refrigerantes. The price is $448 million in cash.
No comments:
Post a Comment